Covetrus reports $37M Q4 loss, promotes acting CEO

Covetrus Inc. (Nasdaq: CVET), the Portland-based provider of animal-health products and services, on Tuesday reported a fourth-quarter net loss of $37 million and announced Benjamin Wolin as its new president and CEO.

In late morning trading Wednesday, shares were up 14%, trading at $12.69. That gives the stock an equity value of around $14.1 billion.

Wolin will transition from the acting role he has held since October when he replaced CEO Benjamin Shaw. Read more

Related Posts

University of Maine recruiting homeowners for tick surveys

ORONO, Maine — With tick season upon us, researchers at the University of Maine want to know what Mainers are doing...

25 April 2023

Maine’s oldest bioscience symposium turns 50 on MDI

Students and accomplished science leaders share research on Mt. Desert Island This April 20 marked the 50th anniversary meeting of the...

23 April 2023

Husson University students, faculty share projects at 13th annual Research Showcase

BANGOR, Maine — Today marked Husson University’s 13th annual Research and Scholarship Day. Students and faculty members at Husson shared the...

20 April 2023